Answers are grounded in this paper and cite their sources.
Understanding the genetic and molecular basis of long QT syndrome allows for genotype-specific risk stratification and targeted therapeutic strategies.
The congenital long QT syndrome is a rare disorder in which mutation carriers are at risk for polymorphic ventricular tachycardia and/or sudden cardiac death. Discovery and analysis of gene mutations associated with variants of this disorder have provided novel insight into mechanisms of cardiac arrhythmia and have raised the possibility of mutation-specific therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Kass et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: